E-LIB Suche - Ergebnisse für: Callander, N.S

1

P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN ..:

Nooka, A. ; Lonial, S. ; Grosicki, S....
HemaSphere. 6 (2022) - p. 829-830 , 2022

Link: https://doi.org/10.1097/..

2

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN ..:

Suvannasankha, A. ; Bahlis, N. ; Trudel, S....
HemaSphere. 6 (2022) - p. 830-831 , 2022

Link: https://doi.org/10.1097/..

3

Outcome with lenalidomide plus dexamethasone followed by ea..:

Biran, N ; Jacobus, S ; Vesole, D H...
Blood Cancer Journal. 6 (2016) 9 - p. e466-e466 , 2016

Link: https://doi.org/10.1038/..

4

Randomized phase III trial of consolidation therapy with bo..:

Jacobus, S J ; Rajkumar, S V ; Weiss, M...
Blood Cancer Journal. 6 (2016) 7 - p. e448-e448 , 2016

Link: https://doi.org/10.1038/..

5

Analysis of Second Primary Malignancies (SPMs) in CALGB (Al..:

Holstein, S.A. ; Owzar, K. ; Richardson, P.G....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e61-e62 , 2015

Link: https://doi.org/10.1016/..

6

Paclitaxel followed by filgrastim for peripheral blood stem..:

McKibbin, T. ; Burzynski, J.A. ; Twombly, R.G....
Biology of Blood and Marrow Transplantation. 12 (2006) 2 - p. 96 , 2006

Link: https://doi.org/10.1016/..

7

LATE ONSET, FATAL GRAFT VS. HOST DISEASE IN A LIVER TRANSPL..:

Pollack, M S. ; Speeg, K V. ; Callander, N S...
Transplantation. 78 (2004) - p. 696 , 2004

Link: https://doi.org/10.1097/..

8

Mechanisms of binding of recombinant extrinsic pathway inhi..:

Callander, N S ; Rao, L V ; Nordfang, O...
Journal of Biological Chemistry. 267 (1992) 2 - p. 876-882 , 1992

Link: https://doi.org/10.1016/..

9

P31 SINGLE-AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELA..:

Nooka, A. ; Cohen, A. ; Lee, H....
HemaSphere. 7 (2023) S2 - p. 27-28 , 2023

Link: https://doi.org/10.1097/..

10

B08 IDECABTAGENE VICLEUCEL VERSUS STANDARD REGIMENS IN PATI..:

Rodríguez-Otero, P. ; Ailawadhi, S. ; Arnulf, B....
HemaSphere. 7 (2023) S2 - p. 7-8 , 2023

Link: https://doi.org/10.1097/..

11

P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL O..:

Usmani, S. ; Hoering, A. ; Ailawadhi, S....
HemaSphere. 6 (2022) - p. 855-856 , 2022

Link: https://doi.org/10.1097/..

12

Autologous hematopoietic cell transplantation for multiple ..:

Mahindra, A ; Hari, P ; Fraser, R...
Bone Marrow Transplantation. 52 (2017) 12 - p. 1616-1622 , 2017

Link: https://doi.org/10.1038/..

13

A247 Bortezomib, Dexamethasone, Cyclophosphamide, Lenalidom..:

Kumar, S ; Flinn, Ian ; Noga, S...
Clinical Lymphoma and Myeloma. 9 (2009) - p. S43-S44 , 2009

Link: https://doi.org/10.1016/..

14

Phase II study of a moderate-intensity preparative regimen ..:

Shaughnessy, P.J ; Ornstein, D ; Ririe, D...
Biology of Blood and Marrow Transplantation. 8 (2002) 8 - p. 420-428 , 2002

Link: https://doi.org/10.1053/..

15

P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN ..:

Nooka, A ; Lonial, S ; Grosicki, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429688/. , 2022

Link: http://www.ncbi.nlm.nih...